IIM
IRMD icon

INTECH Investment Management’s iRadimed IRMD Stock Holding History

INTECH Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231K Sell
2,403
-717
-23% -$71.7K ﹤0.01% 1683
2025
Q4 		$304K Sell
3,120
-646
-17% -$55.4K ﹤0.01% 1760
2025
Q3 		$268K Buy
3,766
+90
+2% +$6K ﹤0.01% 1896
2025
Q2 		$220K Sell
3,676
-745
-17% -$40.8K ﹤0.01% 2040
2025
Q1 		$232K Buy
+4,421
New +$248K ﹤0.01% 2012

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

INTECH Investment Management's IRMD Position: Q1 2026 in Review

INTECH Investment Management reduced its iRadimed (IRMD) stake by 23% in Q1 2026, selling an estimated $71.7K and leaving 2,403 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.

INTECH Investment Management first reported a position in IRMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $304K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • INTECH Investment Management held 2,403 shares of iRadimed worth $231K as of Q1 2026.
  • INTECH Investment Management sold 717 iRadimed shares in Q1 2026, an estimated $71.7K.
  • iRadimed made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1683 holding.
  • INTECH Investment Management first reported a position in iRadimed in Q1 2025 and has held it in 5 quarters since.
  • INTECH Investment Management's iRadimed position peaked at $304K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.